Charity launches £14m UK-wide lung cancer research initiativeBMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f4628 (Published 18 July 2013) Cite this as: BMJ 2013;347:f4628
- Krishna Chinthapalli
A £14m UK study to sequence the genomes of people with lung cancer has been launched by the charity Cancer Research UK.
At a press briefing for the launch on 17 July, Charles Swanton, professor of oncology at University College London, and the project’s lead researcher, highlighted three barriers to new lung cancer treatments that the project could overcome: the difficulty in identifying patients who will have a good response to a drug, inevitable drug resistance in advanced metastatic cancer, and high failure rates in the development of new drugs for cancer treatment.
Swanton said, “The problem with lung cancer is that it has …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial